|
**Host: Texas Scottish Rite
Hospital
**Continental Breakfast
**Online Registration/Prepayment requested
**Call Benita Stiggers for prepayment questions 214. 981.3417
**Free Parking: Maple Ave. lot; for questions regarding directions or
parking call 214.559.7606
Why do some North Texas life science start-up companies get funded
by venture capital while others don't?
Understanding fundamentals is the underlying theme for this forum,
which features venture capitalists successfully investing in our region at
the leading edge of life science technology. Come hear how each of these fund managers has discovered ways
to focus their resources on industry needs. Stay afterward to tour the research and treatment facilities
of our host, Texas Scottish Rite Hospital for Children.
7:00 – 7:30 AM Networking and Breakfast
7:30 – 8:00 AM Meeting and Presentation
9:00 – 9:30 AM TSRH Tours
Please
Register by 5pm Monday, March 3—your credit card pre-payment will allow us
to prepare a name badge for you in advance and will minimize the amount of
time you stand in line at the door.
Call Benita at 214.981.3417 if you cannot prepay with a credit card.
About Dr. Paiva (www.chisholmvc.com):
Dr. Paiva has twelve years of management consulting, biomedical,
and venture capital experience. Prior to joining Chisholm Private Capital,
he managed his own consulting firm providing E-commerce strategy services
and was a management consultant at Pittiglio Rabin Todd & McGrath.
Paiva earned a Ph.D. from the University of Oklahoma while conducting his
dissertation research at the Oklahoma Medical Research Foundation and holds
an MBA from Dartmouth College's Amos Tuck School of Business.
Chisholm Private Capital Partners of Oklahoma City invests in
early-stage companies by contributing cash, contacts, coaching, credibility
and, most importantly, an understanding of the process of creating
shareholder wealth. Chisholm invests in Oklahoma
and it's contiguous
states and opportunistically outside our region.
About Dr Kersey
(www.cogenebiotech.com):
Prior to joining Cogene, Dr. Kersey served as
Partner at Blueprint Ventures and Associate at Menlo Ventures. He has also worked in business
development for Bridge Medical, a medical device and software company; in
health care management consulting with McKinsey & Company; and
completed research fellowships at the National Institutes of Health and the
Emory University School of Medicine.
Kersey graduated from Stanford University with a B.A. in Human
Biology before obtaining a Doctor of Medicine degree from the Emory
University School of Medicine and a Master’s in Business Administration
from the Harvard Business School.
The goal of Houston-based Cogene Biotech Ventures is to gradually
build one of the nation's top life sciences venture capital funds by carefully
investing in leading-edge companies located in both the traditional life
science centers as well as underserved, emerging life science centers in
the Southern tier states.
About Mr.
Hoopingarner (www.emergenttechnologies.com):
Mr. Hoopingarner joined ETI as
Vice-President, New Business Development in May 2000. He was promoted to Executive Vice
President in May 2001; in this assignment he serves as Chief Operating
Officer of Pure Protein, Hyalose and Heparinex.
His business development and
operations experience comes from various domestic and foreign assignments
for Dresser Industries, Brown & Root, SEDCO Inc. and Sedco
Forex-Schlumberger. Hoopingarner
received his Bachelor of Science degree in civil engineering from Southern
Methodist University.
Emergent Technologies Inc. is an Austin-based venture capital firm
that specializes in forming, funding, commercializing, and managing
companies in the Southwest for the purpose of converting institutional and
university-based technology into high return ventures.
About Dr. Luthy (www.luthygroup.com):
Dr. Luthy established MPI in 1996 after a 10-year career
in successive levels of R&D management at Alcon Laboratories, the world
leader in ocular therapies. She
spent the previous two years as Group Leader of Immunoconjugate Chemistry
for BioDiagnostics, Inc, a venture capital-funded start-up company. She currently lectures in the Science
and Technology Commercialization Masters Program at the IC2
Institute at UT Austin. In 2001 and
2002 she served as a judge for the Technology Commercialization Competition
held jointly by IC2 Institute and Austin Technology
Incubator. Luthy holds BA and PhD
degrees in chemistry from Rice University and Penn. State,
respectively. She completed the
Executive MBA Program at SMU’s Cox School of Business May 1998 and founded
DFBT in October of that year.
Medical Product Innovation is a networked scientific and
management consulting company that creates strategies for developing
medical inventions into successful commercial products.
About NTLSS (www.ntlss.org):
The North Texas Life Science Society, formed in May 2002, assists
the transfer of research technology to commercial application, by bringing
together science, investment capital, and management talent to build new life science
businesses.
|
![[ Yahoo! Maps ]](file:///C:/My%20Documents/Connie's%20Documents/DFBT/Current%20Website/March/eventdetail1120_files/yahoo_maps.gif){kind=small}